Tandem Diabetes Care, Inc. (LON:0M0F)
London
· Delayed Price · Currency is GBP · Price in USD 22.73
+0.04 (0.17%)
At close: May 16, 2025
Tandem Diabetes Care Revenue
Tandem Diabetes Care had revenue of $234.42M USD in the quarter ending March 31, 2025, with 22.30% growth. This brings the company's revenue in the last twelve months to $982.95M, up 27.65% year-over-year. In the year 2024, Tandem Diabetes Care had annual revenue of $940.20M with 25.74% growth.
Revenue (ttm)
$982.95M
Revenue Growth
+27.65%
P/S Ratio
1.35
Revenue / Employee
$370.92K
Employees
2,650
Market Cap
1.02B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 940.20M | 192.49M | 25.74% |
| Dec 31, 2023 | 747.72M | -53.50M | -6.68% |
| Dec 31, 2022 | 801.22M | 98.42M | 14.00% |
| Dec 31, 2021 | 702.80M | 203.97M | 40.89% |
| Dec 31, 2020 | 498.83M | 136.53M | 37.68% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| HSBC Holdings | 44.89B |
| Shell | 217.54B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| Rolls-Royce Holdings | 18.91B |